In her article, Professor Kogie Naidoo draws a poignant analogy, equating tuberculosis (TB) to a bridesmaid, consistently overshadowed by more prominent health issues and diseases. She underscores the devastating impact of TB, which remains a leading cause of death from a single infectious agent, with more than 4,000 lives lost daily. Despite the significant scientific advancements made since Mycobacterium tuberculosis was first identified over a century ago, TB continues to be overlooked in terms of both public attention and funding.

The funding disparities highlighted by Naidoo accentuate the urgent need for greater investment in TB research and vaccine development. While the COVID-19 pandemic generated vast amounts of funding for its research and vaccine initiatives, TB only receives approximately $1 billion annually, with a meager portion directed specifically toward vaccine development. This striking contrast raises concerns about the priorities set by global health agencies and governments in combating diseases that disproportionately affect lower-income populations and marginalized communities.

Naidoo calls for a reassessment of global health strategies to elevate TB from its relegated status. As infections and deaths from TB continue to rise, the article serves as a crucial reminder of the need for sustained attention, resources, and comprehensive policies to address the epidemic effectively, ensuring that TB no longer remains in the shadows but receives the critical spotlight it desperately needs.